Physician profile
Mark Coseo
NPI 1386840411
$2,785.32
in general payments reported to CMS, 2019-2025
10 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $443 · 2022: $519 · 2023: $114 · 2024: $1,292 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,288 · Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,287.73 |
| Food and Beverage | $535.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,126.23 | 2024 | Other - Miscellaneous |
| Stryker Corporation | $767.37 | 2021-2024 | Ravine Lateral Access System, Adapt |
| Globus Medical, INC. | $416.86 | 2025 | Excelsius Gps, Tlif |
| Medtronic, INC. | $155.30 | 2021-2024 | Endoskeleton Tc, Unid_pass |
| Boston Scientific Corporation | $151.01 | 2022-2024 | |
| Intrinsic Therapeutics | $98.86 | 2023 | Barricaid Acd (Annular Closure Device) |
| Relievant Medsystems, INC. | $21.27 | 2021 | |
| Si-Bone, INC. | $19.02 | 2022 | |
| Cerapedics INC. | $15.35 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Nevro Corp. | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Coseo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.